Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Valent

Showing results (271-280 of 316) with videos related to

Pageof 32
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domainS Flicker, S Vrtala, P Steinberger, et al.
Leukemia|July 16, 2016
Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosisM Jawhar, J Schwaab, D Hausmann, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2009
CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linkingA W Hauswirth, L Escribano, A Prados, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1995
Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cellsW Füreder, H Agis, M Willheim, et al.
Leukemia|May 24, 2016
Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemiaG Heller, T Topakian, C Altenberger, et al.
Current Cancer Drug Targets|December 15, 2011
The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cellsH Herrmann, M Kneidinger, S Cerny-Reiterer, et al.
Leukemia|January 9, 2015
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late eventM Jawhar, J Schwaab, S Schnittger, et al.
Leukemia & Lymphoma|August 1, 2002
Serum tryptase measurements in patients with myelodysplastic syndromesW R Sperr, B Stehberger, F Wimazal, et al.
Leukemia|February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or bothS Koschmieder, T I Mughal, H C Hasselbalch, et al.
Allergy|July 30, 2015
Epitope specificity determines cross-protection of a SIT-induced IgG4 antibodyE Gadermaier, L K James, M H Shamji, et al.
Pageof 32

Showing results (271-280 of 316) with videos related to

Sort By:
Pageof 32
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domainS Flicker, S Vrtala, P Steinberger, et al.
Leukemia|July 16, 2016
Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosisM Jawhar, J Schwaab, D Hausmann, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2009
CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linkingA W Hauswirth, L Escribano, A Prados, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1995
Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cellsW Füreder, H Agis, M Willheim, et al.
Leukemia|May 24, 2016
Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemiaG Heller, T Topakian, C Altenberger, et al.
Current Cancer Drug Targets|December 15, 2011
The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cellsH Herrmann, M Kneidinger, S Cerny-Reiterer, et al.
Leukemia|January 9, 2015
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late eventM Jawhar, J Schwaab, S Schnittger, et al.
Leukemia & Lymphoma|August 1, 2002
Serum tryptase measurements in patients with myelodysplastic syndromesW R Sperr, B Stehberger, F Wimazal, et al.
Leukemia|February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or bothS Koschmieder, T I Mughal, H C Hasselbalch, et al.
Allergy|July 30, 2015
Epitope specificity determines cross-protection of a SIT-induced IgG4 antibodyE Gadermaier, L K James, M H Shamji, et al.
Pageof 32